Stirling, Scotland – eClinicalHealth Limited, a cloud-based remote clinical research technology company and Chilli Consultancy, a statistical and patient-centered outcomes consulting firm announce new streamlined clinical outcome assessment (COA) development services.
iUsability, a new service to be jointly offered by eClinicalHealth and Chilli Consultancy is a novel patient usability testing service. The Integrated Usability Service or iUsability streamlines the necessary testing of patient reported outcomes (PRO) instruments and other clinical outcome assessment (COA) instruments when migrating from paper to electronic formats (ePRO). The iUsability service optimizes the usability of patient-facing eClinical solutions as well as capturing feedback from all trial stakeholders. Novel aspects of this service include a focus on “Bring Your Own Device” (BYOD) methods that allow patients to use their own existing devices to enter data, as well as the vendor- and device-agnostic approach, which allows the usability testing results to be shared with other companies in the industry. These approaches reflect the future of data capture in clinical trial settings and promote better information sharing in the industry eliminating the current practice of repeated testing of the same instruments.
“The iUsability service fills a void in the eCOA marketplace. Many people own multiple internet-enabled devices. Allowing patients to use their choice of device is very important, it helps avoid compliance issues, reduces patient burden and saves our Sponsors tremendous amounts of money using a future-proof solution. With Integrated Usability Service, we can optimize design to capture the evidence that the instrument’s scientific integrity is maintained when compared to the paper version.” says Kai Langel, Co-Founder and Director of Technology and Patient Solutions at eClinicalHealth.
Another new service jointly offered through eClinicalHealth and Chilli Consultancy is eValidatePRO, which is a remote approach for conducting psychometric validation studies for Clinical Outcomes Assessments (COA/eCOA). Regulators required outcomes assessments for labeling claims to be developed using a rigorous process that includes assessment of the psychometric properties of an instrument prior to the pivotal trial. Since these studies are often on the critical path, eValidatePRO’s remote methodologies streamline this process without sacrificing scientific rigour.
“While the qualitative stages of instrument development are conducted in-person using in-depth interview methodologies with smaller samples of participants, the psychometric validation stage requires much larger populations to complete the new instruments to ensure statistical rigor. Being able to do this remotely, in a quick and efficient manner, importantly decreases the time needed for instrument development. Using remote research for this stage of the instrument development is a real breakthrough in research methodology” says Dr Annabel Nixon, Co-Founder and Director at Chilli Consultancy.
For biopharmaceutical companies that are looking for better ways to conduct outcomes instrument development projects, the partnership between eClinicalHealth and Chilli Consultancy combines modern ClinpalTM technology and remote research expertise with years of PRO, scientific and statistical experience.
About eClinicalHealth
Headquartered in Scotland, eClinicalHealth Limited, developers of the ClinpalTM remote research platform, was founded in 2012 to provide innovative clinical trial solutions. The company is committed to leading open and collaborative innovation discussions about patient-centric clinical trial processes and technology with pharmaceutical companies, CROs and other service and technology providers.
About Chilli Consulting
Headquartered in England, Chilli Consultancy was founded in 2014 as a specialist bespoke statistical and patient-centered outcomes services provider with high-quality delivery as standard.
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.